Contributing to the promotion of health innovation through the use of AI/DX

In October 2022, Findability Sciences Inc., a global provider of AI solutions for enterprises became a member of Shonan Health Innovation Park (Shonan iPark) to support AI implementation in the pharmaceutical and bio industries.

Shonan iPark that began operations in April 2018 is a science park launched by Takeda Pharmaceutical Company by transforming its Shonan research site to provide an open innovation environment, with the aim of creating a co-location ecosystem comprised of industry experts, next-generation medical researchers, AI enterprises, venture startups, government, and academia to become a place to accelerate health innovation. Findability Sciences has become a member of Shonan iPark to contribute to AI/DX promotion among iPark members supported by document/data analytics in pharma & bio development. Findability Sciences Inc. with its head office located in the United States joined the membership, and Findability Sciences K.K., a joint venture with SoftBank Corp. that handles its activities in Japan, will work together at Shonan iPark.

On Friday, October 28, “iPark Membership day,” an event for Shonan iPark’s membership, was held, where Findability Sciences ran a booth as its member for the first time. Isao Matsugaya, board member of Findability Sciences Inc., gave a presentation on the possible use of AI in the pharma & bio field that our company is aiming at, introducing Findability Sciences’ AI solutions and showcasing use cases of IDP solutions. At our booth, we had a chance to communicate with many researchers who are involved in research in this field at Shonan iPark, and exchanged opinions about the current status of this field and the possibility of AI utilization.

Findability Sciences will contribute to health innovation by proposing and providing optimal AI solutions for the pharmaceutical/bioresearch/development fields in collaboration with members of Shonan iPark.

About Findability Sciences

Findability Sciences is a leading enterprise AI company that helps businesses worldwide realize the potential of data and become data superpowers. Continuing to expand its global reach in Japan, India, and the U.S., Findability Sciences was named to Inc. magazine’s annual Inc. 5000 list in 2020 and again in 2022. We at Findability Sciences enable customers across industries and geographies to accelerate their Data-to-AI Journey enabling them to build their own IP and data science capabilities besides executing strategically to derive real financial ROI. Our proprietary platform, Findability.ai, empowers businesses around the world as we solve their most complex and critical business challenges. In simple terms, we drive digital transformation in traditional enterprises by making them data superpowers.